Skip to main content
Clinical Trials/NL-OMON49263
NL-OMON49263
Recruiting
Not Applicable

Frontotemporal dementia Imaging of Neuroinflammation, Degeneration and Microglia-Related Effects - FIND-MORE

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Frontotemporal dementia
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
32
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Able to tolerate the \[18F]DPA\-714 PET\-MRI scan procedures and to make an
  • informed decision to participate in this study
  • \- Symptomatic patients must meet clinical criteria for FTD clinical syndromes
  • \- Presymptomatic individuals and healthy controls must show no objective
  • evidence of cognitive impairment

Exclusion Criteria

  • \- Has contraindications for MRI scanning, e.g. metal objects in the body,
  • claustrophobia
  • \- Has evidence of structural brain abnormalities that are likely to interfere
  • with the interpretation of PET scan
  • \- Has one or more comorbidities that may interfere with the outcomes of the
  • study (e.g. significant immune disease, neurological disease, CNS malignancy)
  • \- Has a history of moderate or severe traumatic brain injury
  • \- Has made use of immunomodulatory or immunosuppressive therapy in the 3 months
  • prior to the scan
  • \- Has any disease or uses medication that may compromise the function of the

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Imaging of neuroinflammation in frontotemporal dementia by means of PET-MRIFrontotemporal dementia (FTD), including symptomatic patients and presymptomatic individuals with genetic mutations predisposing to FTD at a later stage in life.Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
EUCTR2020-002672-12-NLErasmus Medical Center32
Terminated
Phase 1
PET Imaging of Neuroinflammation in Neurodegenerative Diseases Via a Novel Translocator Protein (TSPO) RadioligandDementia
NCT03958630National Institute of Mental Health (NIMH)13
Recruiting
Not Applicable
Advanced MR Neuroimaging in presenile dementianeurodegeneratieve aandoeningendementiaMRI10042258
NL-OMON35133Erasmus MC, Universitair Medisch Centrum Rotterdam120
Active, not recruiting
Phase 1
IMAGING OF NEUROINFLAMMATION AND NEURODEGENERATION INALZHEIMER’S DISEASEmild cognitive impairment and familiar Alzheimer diseaseMedDRA version: 22.1Level: LLTClassification code 10050727Term: RI scanSystem Organ Class: 100000004848Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
EUCTR2015-001211-13-ITOSPEDALE SAN RAFFAELE38
Active, not recruiting
Not Applicable
study of neuroinflammation in pathologies like Alzheimer, mild cognitive impairment, dementia and SLAmild cognitive impairment, Alzheimer disease,frontotemporal dementia, SLAMedDRA version: 14.1Level: LLTClassification code 10050727Term: RI scanSystem Organ Class: 100000004848Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
EUCTR2012-004328-40-ITOSPEDALE S. RAFFAELE DI MILANO